IPOs and Secondaries

IPOs and Secondaries Articles

AveXis has filed with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO).
Oncobiologics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
The first scheduled initial public offering (IPO) did not make it out the door last week, and the company is expected to try again this week. A second IPO is also on the calendar, but it faces its...
Red Rock Resorts has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
McGraw-Hill Education has amended its filing with the Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
PSAV has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Ameriquest expects to price more than 6 million shares in the range of $11 to $13 for an IPO valued up to roughly $92 million.
Two news items from Plains All American Pipeline released Tuesday morning pushed the midstream energy company's shares up nearly 25% shortly after the opening bell.
Beigene has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Elevate Credit has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Clearside Biomedical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
While 2016 initial public offerings are not starting the year with a bang, at least the first IPO of the year is scheduled to occur in the coming week.
That Saudi Arabian Oil Co., better known as Saudi Aramco, is considering selling shares to the public has generated a lot of chatter about what the company might be worth.
Ardelyx recently filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering.
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering.